Key Insights
Pharmaceutical companies should assess AI applications in patient services by focusing on outcomes—such as enhanced patient care and brand performance—rather than solely on cost reductions.
Successful AI implementations must retain essential human interactions, include defined procedures for escalation when automation encounters issues, and uphold rigorous data privacy standards to safeguard patient information.
Leaders in patient access need to strategically deploy AI to address particular brand challenges, avoiding adoption driven solely by industry trends.